Université de Poitiers

Running trials

• Recruiting

  Strategies for zoledronic acid post-denosumab discontinuation in postmenopausal osteoporosis

  2024-511871-13-00· Phase 4· Source

• Active, not recruiting

  A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)

  NCT05629585· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Osteoporosis1 recruiting

Researchers

No researcher is linked here yet.

Trial sites

• Universite De Poitiers3 trials